Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol
Harris, AD, Kotetishvili, M, Shurland, S, et al. How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition. Am J Infect Control
Harris, AD, Perencevich, EN, Johnson, JK, et al. Patient-to-patient transmission is important in extended-spectrum β-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis
Bauernfeind, A, Abele-Horn, M, Emmerling, P, Jungwirth, R. Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae
. J Antimicrob Chemother
Pitout, JD, Wei, Y, Church, DL, Gregson, DB. Surveillance for plasmid-mediated quinolone resistance determinants in Enter-obacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J Antimicrob Chemother
van Hees, BC, Tersmette, M, Willems, RJ, de Jong, B, Biesma, D, van Hannen, EJ. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis. J Antimicrob Chemother
Christiansen, N, Nielsen, L, Jakobsen, L, Stegger, M, Hansen, LH, Frimodt-Moller, N. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country. Microb Drug Resist
Kariuki, S, Revathi, G, Corkill, J, et al.
Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. J Infect Dev Ctries
Lautenbach, E, Metlay, JP, Mao, X, et al. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis
Lautenbach, E, Harris, AD, Perencevich, EN, Nachamkin, I, Tolomeo, P, Metlay, JP. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquino-lone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother
Johnson, JK, Smith, G, Lee, MS, et al. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J Infect Dis
Baum, HV, Franz, U, Geiss, HK. Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients. Infection
Blanco, J, Mora, A, Mamani, R, et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups 025b:H4-B2-ST131, 015:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother
Carratala, J, Fernandez-Sevilla, A, Tubau, F, Dominguez, MA, Gudiol, F. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother
Chang, TM, Lu, PL, Li, HH, Chang, CY, Chen, TC, Chang, LL. Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates. J Chemother
Chen, JY, Siu, LK, Chen, YH, Lu, PL, Ho, M, Peng, CF. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center. Microb Drug Resist
Cheong, HJ, Yoo, CW, Sohn, JW, Kim, WJ, Kim, MJ, Park, SC. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis
Eom, JS, Hwang, BY, Sohn, JW, et al. Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection. Microb Drug Resist
Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol
Garau, J, Xercavins, M, Rodriguez-Carballeira, M, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother
Grude, N, Strand, L, Mykland, H, et al. Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread. Clin Microbiol Infect
Johnson, JR, Johnston, B, Clabots, C, et al.
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother
Johnson, JR, Johnston, B, Clabots, C, Kuskowski, MA, Castanheira, M.
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis
Kern, WV, Andriof, E, Oethinger, M, Kern, P, Hacker, J, Marre, R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother
Kern, WV, Klose, K, AS, Jellen-Ritter, et al.
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis
Kuntaman, K, Lestari, ES, JA, Severin, et al. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis
Lautenbach, E, NO, Fishman, JP, Metlay, et al.
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis
2006; 194: 79–85.
Lehn, N, Stower-Hoffmann, J, Kott, T, et al.
Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance. J Clin Microbiol
JN, Maslow, Lee, B, Lautenbach, E. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility. Emerg Infect Dis
LC, McDonald, FJ, Chen, HJ, Lo, et al.
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother
CN, Mihu, PR, Rhomberg, RN, Jones, Coyle, E, RA, Prince, KV, Rolston.
Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis
Oethinger, M, Conrad, S, Kaifel, K, et al.
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother
Oethinger, M, AS, Jellen-Ritter, Conrad, S, Marre, R, WV, Kern. Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis. Infection
YH, Park, JH, Yoo, DH, Huh, YK, Cho, JH, Choi, WS, Shin. Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes. Yonsei Med J
AS, Pereira, SS, Andrade, Monteiro, J, HS, Sader, AC, Pignatari, AC, Gales. Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitals. Braz J Infect Dis
MA, Pfaller, RJ, Hollis, HJ, Sader. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: HD, Isenberg. Clinical Microbiology Procedures Handbook. 2, suppl. 1.
New York: American Society for Microbiology, 1992:10.5c.1-10.5.c.12.
Perrin, M, PY, Donnio, Heurtin-Lecorre, C, MF, Travert, JL, Avril. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals. J Hosp Infect
Reuter, S, WV, Kern, Sigge, A, et al.
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis
PR, Rhomberg, TR, Fritsche, HS, Sader, RN, Jones. Clonal occurrences of multidrug-resistant gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004). Diagn Microbiol Infect Dis
WH, Sheng, YC, Chen, JT, Wang, SC, Chang, KT, Luh, WC, Hsieh. Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan. Diagn Microbiol Infect Dis
JH, Shin, HJ, Jung, JY, Lee, HR, Kim, JN, Lee, CL, Chang. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. Microb Drug Resist
Tascini, C, Menichetti, F, Bozza, S, et al.
Molecular typing of fluoroquinolone-resistant and fluoroquinolone-susceptible Escherichia coli isolated from blood of neutropenic cancer patients in a single center. Clin Microbiol Infect
Uchida, Y, Mochimaru, T, Morokuma, Y, et al.
Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup 025 strains, and associated virulence factors. Int J Antimicrob Agents
Uchida, Y, Mochimaru, T, Morokuma, Y, et al.
Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia. Int J Antimicrob Agents
CR, Usein, Tatu-Chitoiu, D, Nica, M, et al.
Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates. Roum Arch Microbiol Immunol
van Belkum, A, Goessens, W, van der Schee, C, et al.
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis
MG, van Kraaij, AW, Dekker, Peters, E, Fluit, A, LF, Verdonck, Rozenberg-Arska, M. Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients. Eur J Clin Microbiol Infect Dis
KJ, Vigil, JA, Adachi, Aboufaycal, H, et al.
Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control
KJ, Vigil, JR, Johnson, BD, Johnston, et al.
Escherichia coli pyom-yositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis
Wagenlehner, F, Stower-Hoffmann, J, Schneider-Brachert, W, KG, Naber, Lehn, N. Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents
2000; 15: 207–211.
Wang, A, Yang, Y, Lu, Q, et al. Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China. BMC Infect Dis
LN, Xia, Li, L, CM, Wu, et al. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China. Foodborne Pathog Dis
JH, Yoo, DH, Huh, JH, Choi, et al.
Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea. Clin Infect Dis